Drugs / PH-10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00555646 | Nov 2007 → Sep 2008 | psoriasis | Provectus Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PH-10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00555646 ↗ |
| Known as | rose bengal disodium | “PH-10 (rose bengal disodium 0.001%)” NCT00555646 ↗ |
| Route | Topical | “Topical PH-10 Aqueous Hydrogel” NCT00555646 ↗ |